125 related articles for article (PubMed ID: 24698419)
1. CD5-positive follicular lymphoma characterized by CD25, MUM1, low frequency of t(14;18) and poor prognosis.
Miyoshi H; Sato K; Yoshida M; Kimura Y; Kiyasu J; Ichikawa A; Ishibashi Y; Arakawa F; Nakamura Y; Nakashima S; Niino D; Sugita Y; Ohshima K
Pathol Int; 2014 Mar; 64(3):95-103. PubMed ID: 24698419
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of de novo CD25-positive follicular lymphoma.
Fujiwara S; Muroi K; Tatara R; Matsuyama T; Ohmine K; Suzuki T; Mori M; Nagai T; Tanaka A; Ozawa K
Leuk Lymphoma; 2014 Feb; 55(2):307-13. PubMed ID: 23697843
[TBL] [Abstract][Full Text] [Related]
3. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases.
Li Y; Hu S; Zuo Z; Hong M; Lin P; Li S; Konoplev S; Wang Z; Khoury JD; Young KH; Medeiros LJ; Yin CC
Mod Pathol; 2015 Jun; 28(6):787-98. PubMed ID: 25743023
[TBL] [Abstract][Full Text] [Related]
4. Molecular and clinical progress in follicular lymphoma lacking the t(14;18) translocation (Review).
Zhu Z; Li T; Zhang X; Zhang Z; Zhu D; Lin P; Tu S; Ren W
Int J Oncol; 2020 Jan; 56(1):7-17. PubMed ID: 31789408
[TBL] [Abstract][Full Text] [Related]
5. CD5+ follicular lymphoma: a clinicopathologic study of three cases.
Barry TS; Jaffe ES; Kingma DW; Martin AW; Sorbara L; Raffeld M; Pittaluga S
Am J Clin Pathol; 2002 Oct; 118(4):589-98. PubMed ID: 12375647
[TBL] [Abstract][Full Text] [Related]
6. Good prognosis for follicular lymphoma with estrogen receptor α-positive follicular dendritic cells.
Ohe R; Meng HX; Yamada A; Ye Aung N; Kabasawa T; Tamura Y; Utsunomiya A; Tamazawa N; Kawamura I; Kitaoka T; Suzuki K; Yanagiya R; Toubai T; Ishizawa K; Yamakawa M
Hematol Oncol; 2020 Aug; 38(3):293-300. PubMed ID: 32196124
[TBL] [Abstract][Full Text] [Related]
7. CD5-positive follicular lymphoma: a case report and literature review.
Sekiguchi Y; Imai H; Wakabayashi M; Sawada T; Ichikawa K; Komatsu N; Noguchi M
Intern Med; 2011; 50(8):899-904. PubMed ID: 21498939
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
10. IFR4/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10.
Chen L; Al-Kzayer LF; Liu T; Kobayashi N; Nakazawa Y; Koike K
Pediatr Blood Cancer; 2017 Feb; 64(2):311-314. PubMed ID: 27616053
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
Patel N; Durkin L; Bodo J; Hsi ED
Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
[TBL] [Abstract][Full Text] [Related]
12. A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36.
Katzenberger T; Kalla J; Leich E; Stöcklein H; Hartmann E; Barnickel S; Wessendorf S; Ott MM; Müller-Hermelink HK; Rosenwald A; Ott G
Blood; 2009 Jan; 113(5):1053-61. PubMed ID: 18978208
[TBL] [Abstract][Full Text] [Related]
13. Aggressive CD5-positive B-cell lymphoma after remission of CD5-negative follicular lymphoma with distinct immunoglobulin heavy chain rearrangement and translocation.
Sonoki T; Ishihara S; Uneda S; Hanaoka N; Kurimoto M; Matsuoka H; Nakakuma H
Int J Hematol; 2008 Oct; 88(3):299-303. PubMed ID: 18758895
[TBL] [Abstract][Full Text] [Related]
14. Cytologic differential diagnosis of follicular lymphoma grades 1 and 2 from reactive follicular hyperplasia: cytologic features of fine-needle aspiration smears with Pap stain and fluorescence in situ hybridization analysis to detect t(14;18)(q32;q21) chromosomal translocation.
Kishimoto K; Kitamura T; Fujita K; Tate G; Mitsuya T
Diagn Cytopathol; 2006 Jan; 34(1):11-7. PubMed ID: 16355396
[TBL] [Abstract][Full Text] [Related]
15. [Pathologic characteristics of bone marrow for
CD5 positive small B cell lymphoma].
Peng S; Zhu F; You S; Gong M; Wen Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):374-9. PubMed ID: 27241147
[TBL] [Abstract][Full Text] [Related]
16. Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.
Weinberg OK; Ma L; Seo K; Beck AH; Pai RK; Morales A; Kim Y; Sundram U; Tan D; Horning SJ; Hoppe RT; Natkunam Y; Arber DA
Am J Surg Pathol; 2009 Apr; 33(4):591-8. PubMed ID: 19065102
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features.
Mirza I; Macpherson N; Paproski S; Gascoyne RD; Yang B; Finn WG; Hsi ED
J Clin Oncol; 2002 Feb; 20(3):647-55. PubMed ID: 11821444
[TBL] [Abstract][Full Text] [Related]
18. The t(14;18) translocation is absent from endothelial and follicular dendritic cells of follicular lymphoma (FL) and shows heterogeneous presence in preserved FL mantle zones.
Kosmidis P; Mankel B; Fend F; Adam P
Diagn Pathol; 2018 May; 13(1):25. PubMed ID: 29720207
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of chromosomal abnormalities in follicular lymphoma.
Tilly H; Rossi A; Stamatoullas A; Lenormand B; Bigorgne C; Kunlin A; Monconduit M; Bastard C
Blood; 1994 Aug; 84(4):1043-9. PubMed ID: 8049424
[TBL] [Abstract][Full Text] [Related]
20. Determinants of the t(14;18) translocation and their role in t(14;18)-positive follicular lymphoma.
Kelly RS; Roulland S; Morgado E; Sungalee S; Jouve N; Tumino R; Krogh V; Panico S; Polidoro S; Masala G; Sánchez MJ; Chirlaque MD; Sala N; Gurrea AB; Dorronsoro M; Travis RC; Riboli E; Gunter M; Murphy N; Vermeulen R; Bueno-de-Mesquita HB; Peeters PH; Trichopoulou A; Trichopoulos D; Lagiou P; Nieters A; Canzian F; Kaaks R; Boeing H; Weiderpass E; Stocks T; Melin B; Overvad K; Tjønneland A; Olsen A; Brennan P; Johansson M; Nadel B; Vineis P
Cancer Causes Control; 2015 Dec; 26(12):1845-55. PubMed ID: 26424368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
